» Articles » PMID: 24126863

Interleukin-1β Upregulates Matrix Metalloproteinase-13 Gene Expression Via C-Jun N-terminal Kinase and P38 MAPK Pathways in Rat Hepatic Stellate Cells

Overview
Journal Mol Med Rep
Specialty Molecular Biology
Date 2013 Oct 16
PMID 24126863
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Matrix metalloproteinase-13 (MMP-13) is crucial in the cleavage and remodeling of the extracellular matrix (ECM), and its expression levels are decreased following the induction of liver fibrosis. The aim of the present study was to investigate the role of c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) in interleukin (IL)-1β-mediated MMP-13 gene expression in rat hepatic stellate cells (HSCs). In the present study, we demonstrated that IL-1β is capable of activating JNK and p38 in a time-dependent manner and the inhibition of the JNK pathway is able to increase MMP-13 mRNA expression; however, the inhibition of the p38 MAPK pathway is capable of inhibiting MMP-13 gene expression. These data demonstrate that IL-1β is able to promote MMP-13 mRNA expression in rat HSCs and the JNK and p38 MAPK pathways were involved in this process. In summary, IL-1β-induced MMP-13 mRNA expression is possibly mediated by cytoplasmic JNK and p38 MAPK pathways, and they play a distinct role in this process. Thus, the JNK and p38 MAPK pathway co-operatively mediate MMP-13 mRNA expression in rat HSCs.

Citing Articles

Kehuang capsule inhibits MAPK and AKT signaling pathways to mitigate CCl-induced acute liver injury.

Ni Q, Lin J, Huang W, Yang L, Li R, Tu T Liver Res. 2025; 8(4):269-281.

PMID: 39958915 PMC: 11771260. DOI: 10.1016/j.livres.2024.11.006.


Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis.

Charan H, Dwivedi D, Khan S, Jena G Genes Dis. 2023; 10(2):480-494.

PMID: 37223529 PMC: 10201559. DOI: 10.1016/j.gendis.2021.12.006.


Chitosan degradation products promote healing of burn wounds of rat skin.

Zhang C, Zhang Q, Yang D, Qiao Y, Wang B, Yan J Front Bioeng Biotechnol. 2022; 10:1002437.

PMID: 36304900 PMC: 9592717. DOI: 10.3389/fbioe.2022.1002437.


Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis.

Jangra A, Kothari A, Sarma P, Medhi B, Omar B, Kaushal K Cells. 2022; 11(9).

PMID: 35563807 PMC: 9104939. DOI: 10.3390/cells11091500.


SB203580-A Potent p38 MAPK Inhibitor Reduces the Profibrotic Bronchial Fibroblasts Transition Associated with Asthma.

Paw M, Wnuk D, Nit K, Bobis-Wozowicz S, Szychowski R, Slusarczyk A Int J Mol Sci. 2021; 22(23).

PMID: 34884593 PMC: 8657816. DOI: 10.3390/ijms222312790.